• Caspase-3 Colorimetric Assay Kit: Mechanism, Benchmarking, a

  2026-07-27

  The Caspase-3 Colorimetric Assay Kit enables sensitive apoptosis detection through DEVD-dependent caspase-3 activity measurement. This dossier details its biochemical mechanism, evidence benchmarks, and practical workflow integration. The kit is widely applicable in apoptosis and neurodegeneration research.

• Fenipentol (1-Phenylpentan-1-ol): Precision Modulation in GI

  2026-07-27

  Explore the unique molecular actions of Fenipentol in gastrointestinal and hepatobiliary research. This in-depth analysis emphasizes precision assay design, advanced mechanistic insights, and evidence-based protocol optimization, providing a distinct perspective beyond standard workflows.

• CUDC-907: Protocols for Dual PI3K and HDAC Inhibition in Can

  2026-07-26

  CUDC-907 enables researchers to achieve coordinated inhibition of PI3K and HDAC pathways in established cancer cell models, providing a tool for dissecting cell cycle, apoptosis, and signaling dynamics. It is strictly intended for in vitro research and not for diagnostic or clinical workflows.

• CCK-8 Antagonism of Electroacupuncture Analgesia and Toleran

  2026-07-25

  This article examines the foundational study by Han et al. (1986), which demonstrated that cholecystokinin octapeptide (CCK-8) antagonizes opioid-mediated analgesia from electroacupuncture in rats and contributes to the development of tolerance. The findings clarify CCK-8's role as an endogenous modulator of pain and opioid signaling, with implications for understanding anti-opioid substrates in neurobiology.

• Triacetin in Research: Protocols, Applications, and Troubles

  2026-07-24

  Triacetin (glyceryl triacetate) stands out as a versatile tool for anti-glioblastoma, metabolic, and ocular workflows, offering reproducible results and high chemical stability. Explore how APExBIO’s Triacetin delivers practical advantages, protocol enhancements, and troubleshooting strategies for complex life science assays.

• Valemetostat Dual EZH1/2 Inhibition in Adult T-cell Leukemia

  2026-07-24

  The reference study reports the first approval of valemetostat, a dual EZH1/2 inhibitor, for the treatment of relapsed or refractory adult T-cell leukemia/lymphoma (ATL) in Japan. By targeting complementary epigenetic pathways, valemetostat achieved meaningful clinical responses in an otherwise difficult-to-treat patient population, highlighting the promise of dual epigenetic targeting strategies in hematologic malignancies.

• Type III Collagen Restricts Breast Tumor Progression and Met

  2026-07-23

  This study demonstrates that type III collagen (Col3) serves a tumor-restrictive function in the breast cancer microenvironment. By integrating in vitro, in vivo, and bioinformatic analyses, the authors show that Col3 abundance suppresses tumor growth and metastasis, suggesting its value as a prognostic marker and potential therapeutic target.

• WP1066, JAK2/STAT3 Inhibitor: Applied Workflows in Cancer &

  2026-07-23

  WP1066, a potent cell-permeable JAK2/STAT3 inhibitor from APExBIO, empowers researchers to dissect oncogenic and regenerative signaling with high precision. This guide details optimized protocols, advanced use-cases, and troubleshooting strategies for maximizing experimental rigor across cancer and bone regeneration models.

• Direct Mouse Genotyping Kit Plus: Precision Tools for Neurog

  2026-07-22

  Unlock high-throughput, purification-free mouse genotyping with Direct Mouse Genotyping Kit Plus. This article uniquely examines its impact on neurogenetic model research, integrating recent innovations and expert workflow strategies.

• SMYD2 Inhibition Mitigates Cisplatin-Induced Renal Fibrosis

  2026-07-22

  This study demonstrates that pharmacological inhibition of SMYD2, using compounds such as LLY-507, significantly reduces renal fibrosis and inflammation in a cisplatin-induced chronic kidney disease model. The findings clarify SMYD2’s role in fibrogenic signaling and support targeted epigenetic intervention as a promising research strategy for renal protection.

• Zosuquidar (LY335979): Protocol Enhancements for MDR Reversa

  2026-07-21

  Zosuquidar (LY335979) 3HCl is a highly selective P-glycoprotein inhibitor that redefines multidrug resistance reversal in cancer research. This article delivers workflow-ready protocols, troubleshooting strategies, and practical insights—bridged by new pharmacokinetic findings—to optimize its use for acute myeloid leukemia, non-Hodgkin's lymphoma, and translational MDR studies.

• Hoechst 33258: Precision DNA Staining for Tumor Mechanobiolo

  2026-07-21

  Hoechst 33258 empowers high-resolution DNA visualization in both live and fixed cells, uniquely enabling mechanobiology workflows such as cell cycle analysis and tumor heterogeneity studies. This guide details not just protocols, but also experimental troubleshooting and the translation of novel confocal imaging advances into everyday lab practice.

• Gamithromycin Pharmacodynamics Against MmmSC: In Vitro Insig

  2026-07-20

  This study provides the first rigorous evaluation of Gamithromycin's in vitro pharmacodynamics against Mycoplasma mycoides subspecies mycoides Small Colony (MmmSC), the causative agent of contagious bovine pleuropneumonia (CBPP). By comparing the efficacy of Gamithromycin to established macrolides in both artificial media and bovine serum, the research clarifies potency shifts in physiologic contexts and informs rational antibiotic selection for veterinary respiratory pathogens.

• Arachidonic Acid: Optimizing Eicosanoid Biosynthesis Workflo

  2026-07-20

  Arachidonic Acid is the linchpin for dissecting lipid signaling and eicosanoid biosynthesis in neuroinflammation models. This article translates current research and advanced workflows into actionable protocols and troubleshooting insights, helping you harness APExBIO's Arachidonic Acid for superior experimental design.

• Applied Workflows with Recombinant Human Growth Hormone (GH)

  2026-07-19

  Recombinant Human Growth Hormone (GH) from APExBIO empowers next-generation cell proliferation and bone growth studies by enabling high-sensitivity, reproducible activation of the IGF-1 pathway in vitro. Discover protocol enhancements, troubleshooting strategies, and actionable insights for leveraging this somatotropin in advanced mechanistic research.

16271 records 1/1085 page Next 12345 下5页 Last page